Market Overview

Oncolytics Closes Offering of 8M Shares at $4/Share for Gross Proceeds of $32M

Related ONCY
Ophthotech Mega Million Deal With Novartis; Oncolytics Biotech Brain Cancer Trial Positive Data; Tarena International Solid Results
Oncolytics (ONCY) Enters Oversold Territory - Tale of the Tape

Oncolytics Biotech Inc. (NASDAQ: ONCY) announced today that it has closed its previously announced underwritten public offering of 8.0 million common shares, at a public offering price of US$4.00 per common share.  The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Oncolytics, were approximately US$32.0 million.

Posted-In: News Offerings


Most Popular

Related Articles (ONCY)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters